Workflow
Biopharma development and commercialization
icon
Search documents
Roivant Sciences (NasdaqGS:ROIV) FY Earnings Call Presentation
2026-01-12 23:00
If You Didn't Buy Roivant in 2025, Now Is the Time J.P. Morgan Healthcare Conference January 12, 2026 Forward-Looking Statements This presentation includes forward-looking statements that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial p ...